| Features | |
| Active substance | Clomifen, Yohimbine |
| Also known as | Clomifene Citrate, Clomid, Serophene |
| Blood pressure | Generally does not affect blood pressure significantly |
| Chemical name | 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine citrate |
| Dosage (medical) | Typically, 50 mg daily for 5 days at the beginning of the menstrual cycle |
| Dosage (sports) | Commonly 25-50 mg per day during or at the end of a steroid cycle |
| Effects | Induces ovulation, increases gonadotropin levels, raises serum testosterone levels |
| Formula | C26H28ClNOв€™C6H8O7 |
| Half-life | 5-7 days |
| Hepatotoxicity | Low, rare hepatic metabolism related side effects |
| Lab Test | Can be detected in blood tests |
| Main action | Induces ovulation by inhibiting negative feedback on the hypothalamus, increasing release of pituitary gonadotropins |
| Side effects | Hot flashes, abdominal discomfort, visual disturbances, nausea, and headaches |
| Storage conditions | Store at room temperature away from moisture and heat |
| Substance class | Selective Estrogen Receptor Modulator (SERM) |
| Trade name | Clomid, Serophene |
| Use in sports | Used to restore the natural production of testosterone and minimize the effects of estrogen in the body after the use of anabolic steroids |
| Water Retention | No significant water retention |
| Active ingredient, mg | 25 |
| Release form | Capsule |
| Manufacturer | Elbrus Pharmaceuticals |
| Packing | Packaging (60 capsules) |
-
1,114.35€ 1,311.00€
Available Options
| Brand: | Abdi Ibragim |
|---|---|
| Product Code: | ELB-PK-0663 |
| Availability: | Available |
